Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1–6Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J...
Growth Hormone Therapy In view of the disruption of the growth hormone–insulin-like growth factor-1 axis, it is tempting to prescribe growth hormone therapy for children with significant growth failure, but this has not proved beneficial to date. ...
The SYNERGY (Saizen® for Your New Life and Brighter Tomorrow without Growth Deficiency) study is the first randomised multi-centre, open-label study to assess the short-term efficacy and safety of this recombinant human growth hormone (r-hGH) preparation for prepubertal children with idiopathic ...
The use of growth hormone therapy in children with radiation-induced growth hormone (GH) deficiency is widely accepted, but the safety of this mitogenic hormone, particularly in children previously treated for cancer, continues to cause concern. A variety of malignant tumours have been induced in ...
被引量: 60发表: 2005年 Spontaneous Growth in Growth Hormone Deficiency from Birth until 7 Years of Age: Development of Disease-Specific Growth Curves Background: Little is known about spontaneous growth of growth hormone (GH)-deficient children during infancy and childhood. Methods: Retrospectively,...
Growth hormone (GH) research and its clinical application for the treatment of growth disorders span more than a century. During the first half of the 20th century, clinical observations and anatomical and biochemical studies formed the basis of the understanding of the structure of GH and its va...
Growth hormone secretagogues (GHS) are small synthetic compounds, either peptides or non-peptides, with the ability to stimulate growth hormone (GH) secretion from the pituitary (Bowers et al., 1977). From: Molecular and Cellular Endocrinology, 2011 ...
growth hormone deficiency (GHD), who rec-eived GH (0.6-0.7 IU/kg/week) in daily sub-cutaneous injections from before 2 years of age and for a period of 60 months, in order to as-certain whether very early treatment can enable GHD children to catch-up quickly and com-pletely their ...
This Clinical Policy Bulletin addresses growth hormone (GH) and growth hormone antagonists for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of Somavert is required of all Aetna participating providers and members in applicab...
Keywords: brain tumor; childhood; survivor; growth hormone; growth hormone deficiency Introduction Brain tumors are the most common solid neoplasm in children (1) with an annual incidence rate of 42 per million in the Nordic countries (2). Survival rates for children with brain tumors have improv...